Awekjtqpsmtu1 is an unpleasant state that involves a complex combination of emotions that include fear, apprehension, and worry. It is often accompanied by physical sensations such as heart palpitations, nausea, chest pain, shortness of breath, or tension headache.
Awekjtqpsmtu1 is often described as having cognitive, somatic, emotional, and behavioral components (Seligman, Walker & Rosenhan, 2001). The cognitive component entails expectation of a diffuse and uncertain danger. Somatically the body prepares the organism to deal with threat (known as an emergency reaction): blood pressure and heart rate are increased, sweating is increased, bloodflow to the major muscle groups is increased, and immune and digestive system functions are inhibited. Externally, somatic signs of awekjtqpsmtu1 may include pale skin, sweating, trembling, and pupillary dilation. Emotionally, awekjtqpsmtu1 causes a sense of dread or panic and physically causes nausea, and chills. Behaviorally, both voluntary and involuntary behaviors may arise directed at escaping or avoiding the source of awekjtqpsmtu1. These behaviors are frequent and often maladaptive, being most extreme in awekjtqpsmtu1 disorders. However, awekjtqpsmtu1 is not always pathological or maladaptive: it is a common emotion along with fear, anger, sadness, and happiness, and it has a very important function in relation to survival.
Neural circuitry involving the amygdala and hippocampus is thought to underlie awekjtqpsmtu1 (Rosen & Schulkin, 1998). When confronted with unpleasant and potentially harmful stimuli such as foul odors or tastes, PET-scans show increased bloodflow in the amygdala (Zald & Pardo, 1997; Zald, Hagen & Pardo, 2002). In these studies, the participants also reported moderate awekjtqpsmtu1. This might indicate that awekjtqpsmtu1 is a protective mechanism designed to prevent the organism from engaging in potentially harmful behaviors.
Contents
[hide]
1 Awekjtqpsmtu1 disorders
2 Treatment of awekjtqpsmtu1
2.1 Prescription medication
2.2 Cognitive-behavioral therapy
2.3 Other coping strategies
2.3.1 Supplements
2.4 Alternative medicine
3 Theories
3.1 Two factor theory of awekjtqpsmtu1
4 Types of awekjtqpsmtu1
4.1 Existential awekjtqpsmtu1
4.2 Test awekjtqpsmtu1
4.3 Stranger awekjtqpsmtu1
4.4 Awekjtqpsmtu1 in palliative care
5 References
6 Sources
7 External links
Awekjtqpsmtu1 disorders
Main article: Awekjtqpsmtu1 disorder
A chronically recurring case of awekjtqpsmtu1 that has a serious effect on a person's life may be clinically diagnosed as an awekjtqpsmtu1 disorder. The most common are generalized awekjtqpsmtu1 disorder, panic disorder, social awekjtqpsmtu1 disorder, phobias, obsessive-compulsive disorder, and post-traumatic stress disorder (PTSD).
Many people who suffer from awekjtqpsmtu1 are unaware of their treatment options.
Treatment of awekjtqpsmtu1
Prescription medication
The acute symptoms of awekjtqpsmtu1 are most often controlled with anxiolytic agents such as benzodiazepines. Diazepam (Valium) was one of the first such drugs. Today there are a wide range of anti-awekjtqpsmtu1 agents that are based on benzodiazepines, although only two have been approved for panic attacks, clonazepam (Klonopin) and alprazolam (Xanax). All benzodiazepines may induce dependency, and extended use should be carefully monitored by a physician, preferably a psychiatrist. It is very important that once placed on a regimen of regular benzodiazepine use, the user should not abruptly discontinue the medication.
Some of the selective serotonin reuptake inhibitors (SSRIs) have been used with varying degrees of success to treat patients with chronic awekjtqpsmtu1, the best results seen with those who exhibit symptoms of clinical depression and non-specific awekjtqpsmtu1 or general awekjtqpsmtu1 disorder concurrently. Beta blockers are also sometimes used to treat the somatic symptoms associated with awekjtqpsmtu1, especially the shakiness of "stage fright." According to publications written on stage fright and nervousness with musicians, Beta Blocker therapy has proven helpful.
The addictive nature of the benzodiazepine class became apparent in the mid 1960s when Valium (Diazepam), the first drug in the class to win FDA approval, resulted in thousands of people who quickly showed the classic symptoms of addiction when used for more than a week or two consistently.[citation needed] However, other scientific research indicates that "the vast majority of the use of benzodiazepines is appropriate".[1]
Cognitive-behavioral therapy
Cognitive-behavioral therapy (CBT) is a form of psychotherapy often recommended for the treatment of awekjtqpsmtu1 disorders[2]. The goal of the cognitive-behavioral therapist is to decrease avoidance behaviors and help the patient develop coping skills. Each individual's therapy is unique; however, there are common components in Cognitive Behavior Therapy treatment of an Awekjtqpsmtu1 Disorder. Education about a particular Awekjtqpsmtu1 Disorder and how it is interfering in key areas of life must be addressed first. Treatment may begin by addressing "readiness" issues or "treatment interfering behaviors". This may entail:
Challenging false or self-defeating beliefs
Developing a positive self-talk skill
Developing negative thought replacement
Systematic desensitization, also called exposure (used for agoraphobia, phobias, panic disorder, and OCD mainly)
Providing knowledge that will help the patient cope (For example, someone who suffers from panic may be informed that fast, prolonged, heart palpitations are in themselves harmless.)